Status:
COMPLETED
Study of Medication and Placebo Response in Major Depression
Lead Sponsor:
University of California, Los Angeles
Collaborating Sponsors:
Eli Lilly and Company
Pfizer
Conditions:
Depressive Disorder, Major
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
The primary purpose of the research study is to use recordings of brain electrical activity (through electroencephalogram, or EEG) and symptom measurements to determine whether patients are likely to ...
Eligibility Criteria
Inclusion
- Clinical Diagnosis of Unipolar Major Depression
Exclusion
- Substance Abuse, Psychotic Disorder, History of Severe Head Trauma
Key Trial Info
Start Date :
December 1 2003
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00229476
Start Date
December 1 2003
Last Update
November 7 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCLA Neuropsychiatric Institute & Hospital
Los Angeles, California, United States, 90024